Literature DB >> 10694145

Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain.

S Fernández1, L Arreaza, I Santiago, A Malvar, S Berrón, J A Vazquez, X Hervada, J J Gestal.   

Abstract

In Galicia, Spain, a dramatic increase in the incidence of meningococcal disease was seen in the 1995-6. The annual incidence rose to 11 per 10(5) inhabitants, and 80% of identified strains were C:2b:P1.2,5. This led to the implementation of an intensive A+C vaccination campaign for the population aged 18 months to 19 years. During this campaign the prevalence of carriage in areas with high and low incidence was studied. Nasopharyngeal swabs were taken from 9796 subjects immediately before the administration of meningococcal vaccine, plated onto Thayer-Martin plates, incubated and sent for analysis to the Reference Laboratory for Neisseria in Spain. The prevalence of the C:2b: P1.2,5 strains was 0.6% (95% CI 0.29-0.88) in the high incidence area, and 0.41% (95 % CI 0.00-1.04) in the low incidence area, and that of serogroup C (all strains) 1.36% (95% CI 0.80-1.80) and 0.89% (95% CI 0.09-1.69) respectively. The prevalence of N. meningitidis (all strains) was almost the same in both areas (8%). Carriers of the epidemic strain were not found in the 2-4 year age group, that most affected by the disease. Our data showed a wide distribution but a low carriage rate of the epidemic strain C:2b:P1.2,5 in the high and low disease incidence areas studied; the difference in the carriage rates between the two areas was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10694145      PMCID: PMC2810768          DOI: 10.1017/s0950268899003027

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

1.  Interruption of siaD in a meningococcal carrier isolate mediated by an insertion sequence.

Authors:  L Arreaza; B Alcalá; C Salcedo; J A Vázquez
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

3.  Risk Analysis by Age on the Burden of Meningococcal Disease in Spain.

Authors:  Irene Rivero-Calle; Peter Francis Raguindin; Jacobo Pardo-Seco; Federico Martinon-Torres
Journal:  Vaccines (Basel)       Date:  2022-04-12

4.  Epidemiology of meningococcal disease in Switzerland, 1999-2002.

Authors:  H Jaccard Ruedin; B Ninet; E Pagano; P Rohner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

5.  Meningococcal carriage during a clonal meningococcal B outbreak in France.

Authors:  V Delbos; L Lemée; J Bénichou; G Berthelot; M-K Taha; F Caron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

6.  Implementation and impact of a meningococcal C conjugate vaccination program in 13- to 25-year-old individuals in Galicia, Spain.

Authors:  Elena Rego Romero; Victoria Nartallo Penas; José Antonio Taboada Rodríguez; Alberto Malvar Pintos; Xurxo Hervada Vidal; María José López Pimentel
Journal:  Z Gesundh Wiss       Date:  2011-03-16

7.  Identification of the nasopharyngeal carriage of Neisseria meningitidis by 16S rRNA Gene sequencing in asymptomatic adolescents and young adults in Cartagena, Colombia (2019-2020).

Authors:  Marlon Macias-Mendoza; Alfredo Montes-Robledo; Cindy Arteta-Acosta; Rosa Baldiris-Avila; Wilfrido Coronell-Rodríguez
Journal:  Braz J Infect Dis       Date:  2022-02-15       Impact factor: 3.257

8.  Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain.

Authors:  Belén Alcalá; Luisa Arreaza; Celia Salcedo; María J Uría; Laura De La Fuente; Julio A Vázquez
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

9.  Serogroup C meningococci in Italy in the era of conjugate menC vaccination.

Authors:  Paola Stefanelli; Cecilia Fazio; Tonino Sofia; Arianna Neri; Paola Mastrantonio
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

10.  Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain).

Authors:  Lina Pérez-Breva; Rafael J Villanueva; Javier Villanueva-Oller; Luis Acedo; Francisco Santonja; José A Moraño; Raquel Abad; Julio A Vázquez; Javier Díez-Domingo
Journal:  BMC Infect Dis       Date:  2014-05-21       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.